
Metabolic side effects of antipsychotic drugs can have serious health consequences and may increase mortality. Although persons with schizophrenia often take these drugs for a long time, their mid‐ to long‐term metabolic effects have been studied little so far. This study aimed to evaluate the mid to long‐term metabolic side effects of 31 antipsychotics in persons with schizophrenia. The findings indicated that antipsychotic drugs differ in their propensity to induce metabolic side effects in mid to long‐term treatment. Since schizophrenia is often a chronic disorder, these findings should be considered in the drug choice for more than a short-term disorder.
Like
Save
Share